We're so glad you're here! This site is to help anyone diagnosed with Medullary Thyroid Cancer and their caregivers find valuable information and support. If you'd like to connect with others with MTC, please consider joining our very active Facebook Group. You don't have to go through this alone!
If you don't yet have a copy, please download the American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma, aka "The Guidelines." This is the MTC Bible. Read it and know it and it will help you and your doctor ensure you get the proper treatment.
Lastly, please consider looking into being seen by an MTC expert. We do our best to keep a running list of what we call "Centers of Excellence." These are doctors and facilities that are properly trained and experienced enough to treat MTC patients. It's one of the most important decisions you can make on your journey.
"NEW YORK Some lung cancer patients with RET fusion-positive tumors were alive around four years on Rigel Pharmaceuticals' Gavreto (pralsetinib), ..."
"Foundayo should not be used by people with a personal or family history of medullary thyroid cancer or in those with Multiple Endocrine Neoplasia ..."
"Gavreto also hit an obstacle when sponsors withdrew its FDA approval for RET-mutant advanced medullary thyroid cancer in 2023. Blueprint and Roche ..."
"Who this is not for: Anyone with a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (black-box warning ..."
"... medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Patients with a history of pancreatitis, certain types of kidney ..."
This website is intended for educational purposes only. It is not intended, nor should it be interpreted, as medical advice or instructions of any kind. Readers are advised to consult their own medical doctor(s) for all matters involving their health and medical care.